Article Data

  • Views 2500
  • Dowloads 111

Original Research

Open Access

Perineural invasion in early-stage cervical cancer: detection and influence on prognosis

  • Y. Long1
  • D.-s. Yao1,*,
  • Y.-s. Wei1
  • J. Chen2
  • X.-q. Ye2

1Department of Gynecologic Oncology, China

2Department of Pathology, Affiliated Tumor Hospital of Guang Xi Medical University, Nanning (People’s Republic of China)

DOI: 10.12892/ejgo4702.2019 Vol.40,Issue 3,June 2019 pp.452-456

Published: 10 June 2019

*Corresponding Author(s): D.-s. Yao E-mail: yds201610@126.com

PDF (478.96 kB) View Full-text

Abstract

Purpose: To compare staining methods for detecting perineural invasion (PNI) in early-stage cervical cancer and assess the influence of PNI on survival. Materials and Methods: The authors retrospectively analysed data on 300 patients treated between 2010 and 2014 for cervical cancer in Stages Ia2-IIb. Rates of PNI detection using Hematoxylin-Eosin (HE) or anti-S-100 protein staining were compared. Influence of PNI on disease-free survival (DFS) and overall survival (OS) were assessed in all patients and in subgroups based on use of adjuvant therapy and nerve-sparing radical hysterectomy (NSRH). Results: Among the 300 patients, HE staining detected PNI in 38 (12.7%) and anti-S-100 staining detected PNI in 45 (15.0%, p = 0.016). PNI was associated with significantly shorter DFS (p = 0.015) and OS (p = 0.020), but it was not an independent risk factor for poor DFS or OS. Significantly higher proportions of patients with PNI received adjuvant radiotherapy or chemo-radiotherapy than patients without PNI (p < 0.001), but the two groups of patients showed similar DFS (p = 0.293) and OS (p = 0.329). Conclusion: Patients with PNI showed significantly longer DFS if they received adjuvant therapy (p = 0.039). Patients who underwent NSRH showed similar DFS and OS as those who did not, regardless of their PNI status. Anti-S-100 staining detects PNI better than HE in patients with early-stage cervical cancer. PNI is associated with poor survival, which can be improved through adjuvant therapy. NSRH does not appear to adversely affect survival of patients with or without PNI.

Keywords

Cervical cancer; Perineural invasion; Staining method; Prognosis.

Cite and Share

Y. Long,D.-s. Yao,Y.-s. Wei,J. Chen,X.-q. Ye. Perineural invasion in early-stage cervical cancer: detection and influence on prognosis. European Journal of Gynaecological Oncology. 2019. 40(3);452-456.

References

[1] Rapidis AD., Givalos N., Gakiopoulou H., Faratzis G., Stavrianos SD., Vilos GA., et al.: “Adenoid cystic carcinoma of the head and neck. Clinicopathological analysis of 23 patients and review of the literature“. Oral Oncol., 2005, 41, 328.

[2] Ju J., Li Y., Chai J., Ma C., Ni Q., Shen Z., et al.: “The role of perineural invasion on head and neck adenoid cystic carcinoma prognosis: a systematic review and meta-analysis“. Oral Surg. Oral Med. Oral Pathol. Oral Radiol., 2016, 122, 691.

[3] Zhang J.F., Hua R., Sun Y.W., Liu W., Huo Y.M., Liu D.J., et al.: “Influence of perineural invasion on survival and recurrence in patients with resected pancreatic cancer“. Asian Pac. J. Cancer Prev., 2013, 14, 5133.

[4] Harnden P., Shelley MD., Clements H., Coles B., Tyndale-Biscoe RS., Naylor B., et al.: “The prognostic significance of perineural invasion in prostatic cancer biopsies: a systematic review”. Cancer, 2007, 109, 13.

[5] Knijn N., Mogk SC., Teerenstra S., Simmer F., Nagtegaal ID.: “Perineural Invasion is a Strong Prognostic Factor in Colorectal Cancer: A Systematic Review”. Am. J. Surg. Pathol., 2016, 40, 103.

[6] Liebig C., Ayala G., Wilks JA., Berger DH., Albo D.: “Perineural invasion in cancer: a review of the literature”. Cancer, 2009, 115, 3379.

[7] Memarzadeh S., Natarajan S., Dandade DP., Ostrzega N., Saber PA., Busuttil A., et al.:” Lymphovascular and perineural invasion in the parametria: a prognostic factor for early-stage cervical cancer“. Obstet Gynecol 2003;102: 612-619.

[8] Elsahwi K.S., Barber E., Illuzzi J., Buza N., Ratner E., Silasi D.A., et al.: “The significance of perineural invasion in early-stage cervical cancer”. Gynecol. Oncol., 2011, 123, 561.

[9] Meinel A., Fischer U., Bilek K., Hentschel B., Horn LC.: “Morphological parameters associated with perineural invasion (PNI) in carcinoma of the cervix uteri”. Int. J. Surg. Pathol., 2011, 19, 159.

[10] Cho H.C., Kim H., Cho HY., Kim K., No J.H., Kim Y.B.: “Prognostic significance of perineural invasion in cervical cancer”. Int. J. Gynecol. Pathol., 2013, 32, 228.

[11] Wei Y.S., Yao D.S., Long Y.: “Evaluation of the association between perineural invasion and clinical and histopathological features of cervical cancer”. Mol. Clin. Oncol., 2016, 5, 307.

[12] Horn L.C., Meinel A., Fischer U., Bilek K., Hentschel B.: “Perineural invasion in carcinoma of the cervix uteri—prognostic impact”. J. Cancer Res. Clin. Oncol., 2010, 136, 1557.

[13] Tian N., Kuerban G.: “The significance of perineural invasion as a prognostic factor in cervical cancer patients of different ethnicities. International Journal of Clinical and Experimental MedicineInt”. J. Clin. Exp. Med., 2016, 9, 19634.

[14] Vural C., Bayrak B.Y., Muezzınoglu B., Yucesoy I.: “Perineural invasion is a valuable prognostic factor in advanced stage and/or Node (+) cervical cancer”. Indian J. Pathol. Microbiol., 2017, 60, 27.

[15] Skret-Magierlo J.E., Soja P.J., Skret A., Kruczek A., Kaznowska E., Wicherek L.: “Perineural space invasion in cervical cancer (FIGO IB1-IIB) accompanied by high-risk factors for recurrence”. J. Cancer Res. Ther., 2014, 10, 957.

[16] Ozan H., Ozuysal S., Ediz B.: “Perineural invasion in early-stage cervical carcinoma”. Eur. J. Gynaecol. Oncol., 2009, 30, 379.

[17] Kurtz K.A., Hoffman H.T., Zimmerman M.B., Robinson R.A.: “Perineural and vascular invasion in oral cavity squamous carcinoma: increased incidence on re-review of slides and by using immunohistochemical enhancement”. Arch. Pathol. Lab. Med., 2005, 129, 354.

[18] Shimada Y., Kido T., Kameyama H., Nakano M., Yagi R., Tajima Y., et al.: “Clinical significance of perineural invasion diagnosed by immunohistochemistry with anti-S100 antibody in Stage I-III colorectal cancer”. Surg. Today, 2015, 45, 1493.

[19] Ryu H.S., Chun M., Chang K.H., Chang H.J., Lee J.P.: “Postoperative adjuvant concurrent chemoradiotherapy improves survival rates for high-risk, early stage cervical cancer patients”. Gynecol. Oncol., 2005, 96, 490.

[20] Song S., Song C., Kim H.J., Wu H.G., Kim J.H., Park N.H., et al.: “20 year experience of postoperative radiotherapy in IB-IIA cervical cancer patients with intermediate risk factors: impact of treatment period and concurrent chemotherapy”. Gynecol. Oncol., 2012, 124, 63.

[21] Long Y., Yao D.S., Pan X.W., Ou T.Y.: “Clinical efficacy and safety of nerve-sparing radical hysterectomy for cervical cancer: a systematic review and meta-analysis”. PLoS One, 2014, 9, e94116.

[22] van Gent M.D., Romijn L.M., van Santen K.E., Trimbos J.B., de Kroon C.D.: “Nerve-sparing radical hysterectomy versus conventional radical hysterectomy in early-stage cervical cancer. A systematic review and meta-analysis of survival and quality of life”. Maturitas, 2016, 94, 30.

[23] Basaran D., Dusek L., Majek O., Cibula D.: “Oncological outcomes of nerve-sparing radical hysterectomy for cervical cancer: a systematic review”. Ann. Surg. Oncol., 2015, 22, 3033.

[24] Cui L., Shi Y., Zhang GN.: “Perineural invasion as a prognostic factor for cervical cancer: a systematic review and meta-analysis”. Arch. Gynecol. Obstet., 2015, 292, 13.

Submission Turnaround Time

Top